ClassID:

94280

C07D215/40 - CPC Classification

Classification description:

Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Nitrogen atoms attached in position 8

Recent Application in this class:
#1
20260138955
2026-05-21

METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED AMPK PROTEIN

#2
20260125340
2026-05-07

METHOD FOR PREPARING AMIDES FROM ESTERS

#3
20250346563
2025-11-13

HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN

#4
20250270445
2025-08-28

COMPOUNDS AND USES THEREOF IN FIELD OF OPTOELECTRONICS

#5
20250034139
2025-01-30

AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY

#6
20240360083
2024-10-31

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#7
20240246915
2024-07-25

AMINONAPHTHOQUINONE COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR BLOCKING UBIQUITINATION-PROTEASOME SYSTEM IN DISEASES

#8
20240174613
2024-05-30

Compounds for the Treatment Of Acute and Chronic Kidney Disease

#9
20240148744
2024-05-09

SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES

#10
20240082233
2024-03-14

Regimens of Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects

#11
20230339860
2023-10-26

Compounds for the treatment of acute and chronic kidney disease

#12
20230250067
2023-08-10

Caspase inhibitors and methods of use thereof

#13
20230146776
2023-05-11

COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF

#14
20230141034
2023-05-11

ADAMANTANE-1-CARBONYL THIOUREA, AS P2X RECEPTOR ANTAGONIST

#15
20230100875
2023-03-30

Heterocyclic compounds as immunomodulators

#16
20230041576
2023-02-09

METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY

#17
20220402883
2022-12-22

COMPOUNDS AND METHODS FOR MODULATING RNA FUNCTION

#18
20220388953
2022-12-08

COMPOUNDS WITH ANTIMICROBIAL ACTIVITY

#19
20220340533
2022-10-27

METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED AMPK PROTEIN

#20
20220267281
2022-08-25

UNSATURATED HETEROCYCLOALKYL AND HETEROAROMATIC ACYL HYDRAZONE LINKERS, METHODS AND USES THEREOF

#21
20220251043
2022-08-11

HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN

#22
20220153702
2022-05-19

Compounds for the treatment of acute and chronic kidney disease

#23
20220144826
2022-05-12

Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related Disorders

#24
20220064142
2022-03-03

Acyl hydrazone derivative compounds for treating disease

#25
20220048898
2022-02-17

Quinolines that modulate SERCA and their use for treating disease

#26
20210332038
2021-10-28

6H-imidazo[4,5,1-ij]quinolone, synthesis method and use thereof

#27
20210269404
2021-09-02

QUINOLINE AMINES USEFUL AS CYTOPROTECTIVE AGENTS

#28
20210267962
2021-09-02

Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

#29
20210198206
2021-07-01

Therapeutic compounds and compositions

#30
20210163476
2021-06-03

Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#31
20210155612
2021-05-27

α,β-unsaturated amide compound

#32
20210040049
2021-02-11

ANTI-HCMV COMPOSITIONS AND METHODS

#33
20200407357
2020-12-31

Heterocyclic compounds as immunomodulators

#34
20200385354
2020-12-10

Quinoline sulfonamide compounds and their use as antibacterial agents

#35
20200385344
2020-12-10

Compounds and pharmaceutical composition associated with ubiquitination-proteasome system

#36
20200347038
2020-11-05

QUINOLINES THAT MODULATE SERCA AND THEIR USE FOR TREATING DISEASE

#37
20200283396
2020-09-10

Caspase inhibitors and methods of use thereof

#38
20200268729
2020-08-27

CXCR4 antagonists with amino acid skeleton, preparation therefor and biomedical use thereof

#39
20200262784
2020-08-20

Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

#40
20200188706
2020-06-18

Neuroprotective quinoline sulfonamides

#41
20200148643
2020-05-14

Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases

#42
20200071344
2020-03-05

Methods for making quinolinyldiamines

#43
20200039939
2020-02-06

QUINOLINE AMINES USEFUL AS CYTOPROTECTIVE AGENTS

#44
20190345109
2019-11-14

Therapeutic compounds and compositions

#45
20190328723
2019-10-31

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

#46
20190284141
2019-09-19

Histone deacetylase 6 inhibitors and use thereof

#47
20190256472
2019-08-22

Photochromic hydrazone switches

#48
20190256471
2019-08-22

SMALL MOLECULE INHIBITORS OF BOTULINUM NEUROTOXINS

#49
20190241523
2019-08-08

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#50
20190194193
2019-06-27

Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#51
20190144383
2019-05-16

Compounds and pharmaceutical composition associated with ubiquitination-proteasome system

#52
20190092730
2019-03-28

Tetradentate chelating monoquinoline derivative, manufacturing method thereof, and application of same as metal ion regulator for neurodegenerative disease

#53
20190016670
2019-01-17

Trifluoromethoylation of arenes via intramolecular trifluoromethoxy group migration

#54
20180319749
2018-11-08

Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases

#55
20180298000
2018-10-18

AMINOQUINOLINE COMPOUNDS HAVING ANTICANCER ACTIVITY

#56
20180282296
2018-10-04

Substituted amides for treating and preventing cancer

#57
20180207628
2018-07-26

Oxalic amide ligands, and uses thereof in copper-catalyzed coupling reaction of aryl halides

#58
20180170884
2018-06-21

Anti-HCMV compositions and methods

#59
20180141911
2018-05-24

Quinoline Derivatives for Diagnosis and Treatment of Alzheimer's Disease

#60
20170360768
2017-12-21

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

#61
20170298008
2017-10-19

Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

#62
20170174679
2017-06-22

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

#63
20170066712
2017-03-09

NOVEL MOLECULES THAT SELECTIVELY INHIBIT HISTONE DEACETYLASE 6 RELATIVE TO HISTONE DEACETYLASE

#64
20160347708
2016-12-01

Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides

#65
20160304461
2016-10-20

QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITION

#66
20160271278
2016-09-22

Tau imaging probe

#67
20160068490
2016-03-10

Ubiquitination inhibitors

#68
20160008494
2016-01-14

Tau imaging probe

#69
20150361077
2015-12-17

Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#70
20150357575
2015-12-10

Amine-based compound and organic light-emitting device including the same

#71
20150322052
2015-11-12

Aryl substituted carboxamide derivatives as calcium or sodium channel blockers

#72
20150307538
2015-10-29

USE OF THERMALLY-TREATED SUPPORTED COBALT CATALYSTS COMPRISING A POLYCYCLIC AROMATIC STRUCTURE CONSISTING OF NITROGEN LIGANDS FOR HYROGENATING AROMATIC NITRO COMPOUNDS

#73
20150080472
2015-03-19

Treatment of friedreich's ataxia using histone deacetylase inhibitors

#74
20150031663
2015-01-29

PHTHALANILATE COMPOUNDS AND METHODS OF USE

#75
20140364424
2014-12-11

Sulfonaminoquinoline hepcidin antagonists

#76
20140296529
2014-10-02

Bis-quinaldine compound and a process for preparing the same

#77
20140288311
2014-09-25

Bis-quinophthalone pigment and a process for preparing the same

#78
20140288119
2014-09-25

Molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1

#79
20140275165
2014-09-18

COMPOUNDS THAT INHIBIT NFkB AND BACE1 ACTIVITY

#80
20140235702
2014-08-21

Small molecule inhibitors of Mcl-1 and the uses of thereof

#81
20140200239
2014-07-17

Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same

#82
20140073668
2014-03-13

N-quinolin-benzensulfonamides and related compounds for the treatment of cancer, autoimmune disorders and inflammation

#83
20140073500
2014-03-13

CLASS OF ORGANIC COMPOUNDS CONTAINING HETEROATOM AND ITS APPLICATIONS IN PREPARING SINGLE-SITE ZIEGLER-NATTA CATALYST

#84
20140072555
2014-03-13

Inhibitor compounds and cancer treatment methods

#85
20140045855
2014-02-13

Chroman derivatives as TRPM8 inhibitors

#86
20140045793
2014-02-13

Quinolone compound and pharmaceutical composition

#87
20140031368
2014-01-30

SELECTIVE HDAC INHIBITORS

#88
20130324523
2013-12-05

Tau imaging probe

#89
20130224760
2013-08-29

Zinc-responsive peptides, and methods of use thereof

#90
20130203733
2013-08-08

COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES

#91
20130143917
2013-06-06

(2E)-3-phenyl-N-[2,2,2-Trifluoro-1-[[8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof

#92
20130123300
2013-05-16

Urea compounds and use thereof for inhibiting apoptosis

#93
20130102631
2013-04-25

NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES

#94
20130096138
2013-04-18

NOVEL THIOUREA OR UREA DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS, CONTAINING SAME AS ACTIVE INGREDIENT

#95
20130079524
2013-03-28

Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives

#96
20130053333
2013-02-28

Aminoquinoline Derivatives

#97
20130005675
2013-01-03

Quinolone compound and pharmaceutical composition

#98
20120316168
2012-12-13

Quinolone compound and pharmaceutical composition

#99
20120277265
2012-11-01

Polyquinoline derivatives and the therapeutic use thereof

#100
20120232150
2012-09-13

Phthalanilate compounds and methods of use

#101
20120214803
2012-08-23

Novel Sulfonaminoquinoline Hepcidin Antagonists

#102
20120195887
2012-08-02

Inhibitor compounds and cancer treatment methods

#103
20120189614
2012-07-26

Inhibitors of filovirus entry into host cells

#104
20120101105
2012-04-26

Aryl substituted carboxamide derivatives as calcium or sodium channel blockers

#105
20120064099
2012-03-15

Compounds that inhibit NFκB and BACE1 activity

#106
20110294848
2011-12-01

Small molecule inhibitors of botulinum neurotoxins

#107
20110281908
2011-11-17

Aminoquinoline Derived Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use

#108
20110269761
2011-11-03

ARYLSULPHONYLGLYCINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS MEDICAMENTS

#109
20110269705
2011-11-03

Quinolone compound and pharmaceutical composition

#110
20110251180
2011-10-13

PHARMACEUTICAL AGENT COMPRISING QUINOLONE COMPOUND

#111
20110112282
2011-05-12

IDO INHIBITORS AND THERAPEUTIC USES THEREOF

#112
20110105747
2011-05-05

Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same

#113
20110046110
2011-02-24

Quinolines and related analogs as sirtuin modulators

#114
20110045100
2011-02-24

Antimalarial Quinolines and Methods of Use Thereof

#115
20110021562
2011-01-27

TREATMENT OF FRIEDREICH'S ATAXIA USING HISTONE DEACETYLASE INHIBITORS

#116
20100331307
2010-12-30

Therapeutic compounds and compositions

#117
20100222330
2010-09-02

New Compounds

#118
20100197925
2010-08-05

Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives

#119
20100160327
2010-06-24

Modified malonate derivatives

#120
20100152165
2010-06-17

CARBOXYLIC ACID DERIVATIVES

#121
20100130546
2010-05-27

Quinolone compound and pharmaceutical composition

#122
20100105915
2010-04-29

CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS

#123
20100076017
2010-03-25

SITAMAQUINE TOSYLATE FOR THE TREATMENT OF LEISHMANIASIS

#124
20100075953
2010-03-25

SUBSTITUTED PIPERAZINES, (1,4) DIAZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS

#125
20100063282
2010-03-11

Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof

#126
20100048669
2010-02-25

Therapeutic compounds

#127
20100015140
2010-01-21

Inhibitor compounds and cancer treatment methods

#128
20090286801
2009-11-19

Carbonylated (aza) cyclohexanes as dopamine Dreceptor ligands

#129
20090286793
2009-11-19

PDE4B inhibitors and uses therefor

#130
20090264425
2009-10-22

CHEMICAL COMPOUNDS

#131
20090253694
2009-10-08

Fused hetrocyclic compounds

#132
20090247509
2009-10-01

Heterocyclic substituted carbonyl derivatives and their use as dopamine Dreceptor ligands

#133
20090227626
2009-09-10

Polyquinoline derivatives and therapeutic use thereof

#134
20090179553
2009-07-16

ELECTROLUMINESCENT MATERIAL CONTAINING AN ORGANIC LUMINESCENT SUBSTANCE

#135
20090143425
2009-06-04

Compounds affecting gap junction activity

#136
20090137383
2009-05-28

CLASS OF ORGANIC COMPOUNDS CONTAINING HETEROATOM AND ITS APPLICATIONS IN PREPARING SINGLE-SITE ZIEGLER-NATTA CATALYST

#137
20090105474
2009-04-23

Anthranilic acid derivative or salt thereof

#138
20090082378
2009-03-26

DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE B2 ADRENERGIC RECEPTOR

#139
20090076072
2009-03-19

DEUTERIUM-ENRICHED TAFENOQUINE

#140
20090048224
2009-02-19

COMPOUNDS AND METHODS OF USE

#141
20090023786
2009-01-22

Histone deacetylase inhibitor prodrugs

#142
20090023718
2009-01-22

Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives

#143
20080312221
2008-12-18

QUINOLINE DERIVATIVE AND QUINAZOLINE DERIVATIVE INHIBITING SELF-PHOSPHORYLATION OF HEPATOCYTUS PROLIFERATOR RECEPTOR, AND MEDICINAL COMPOSITION CONTAINING THE SAME

#144
20080293711
2008-11-27

Chemokine receptor modulators

#145
20080255359
2008-10-16

Novel Chemical Process For the Synthesis of Quinoline Compounds

#146
20080249092
2008-10-09

Novel Quinoline Compounds Capable Of Binding At The Cb2 Receptor

#147
20080220003
2008-09-11

C5a receptor antagonists

#148
20080188490
2008-08-07

Acetylene Derivatives

#149
20080119538
2008-05-22

Therapeutic compounds

#150
20080096920
2008-04-24

Histone deacetylase inhibitors

#151
20080090846
2008-04-17

CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS

#152
20080058523
2008-03-06

Processes for synthesizing piperazine-piperidine compounds

#153
20080009489
2008-01-10

ANDROGEN RECEPTOR MODULATORS AND METHOD OF TREATING DISEASE USING THE SAME

#154
20080004290
2008-01-03

Anti-Cancer Agents

#155
20070219244
2007-09-20

Histone deacetylase inhibitors as therapeutics for neurological diseases

#156
20070167410
2007-07-19

Immunosuppressant compounds and compositions

#157
20070161641
2007-07-12

Heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands

#158
20070142246
2007-06-21

Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions

#159
20070142245
2007-06-21

Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions

#160
20070099919
2007-05-03

Composition and synthesis of new reagents for inhibition of HIV replication

#161
20070066600
2007-03-22

Substituted naphthalene sulfonamides

#162
20070066599
2007-03-22

New compounds

#163
20070066598
2007-03-22

Compounds

#164
20070060757
2007-03-15

Synthesis of enantiomerically pure amino-substituted fused bicyclic rings

#165
20070032504
2007-02-08

Polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline

#166
20070027161
2007-02-01

Aryloxy quinolines and uses thereof

#167
20070027139
2007-02-01

Piperazinyl-quinoline derivatives useful for the treatment of CNS disorders

#168
20070021612
2007-01-25

Processes and compounds for preparing histone deacetylase inhibitors and intermediates thereof

#169
20070010669
2007-01-11

Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

#170
20070010536
2007-01-11

Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

#171
20070004679
2007-01-04

Androgen receptor modulators and methods of treating disease using the same

#172
20060287334
2006-12-21

Quinoline compounds and pharmeceutical compositions containing them

#173
20060264434
2006-11-23

Chemokine receptor binding heterocyclic compounds

#174
20060264415
2006-11-23

Inhibitors of histone deacetylase

#175
20060252795
2006-11-09

Chemokine receptor binding heterocyclic compounds

#176
20060241129
2006-10-26

Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

#177
20060229333
2006-10-12

Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors

#178
20060074105
2006-04-06

Substituted quinoline and quinazoline inhibitors of quinone reductase 2

#179
20060041006
2006-02-23

PDE4B inhibitors and uses therefor

#180
20060025404
2006-02-02

Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists

#181
20060014739
2006-01-19

Androgen receptor modulators and method of treating disease using the same

#182
20050250770
2005-11-10

Fused heterocyclic compounds

#183
20050239833
2005-10-27

Compositions and methods for modulating interaction between polypeptides

#184
20050209277
2005-09-22

Process for the synthesis of CXCR4 antagonist

#185
20050165054
2005-07-28

Process for the preparation of quinoline derivatives

#186
20050165050
2005-07-28

Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors

#187
20050124654
2005-06-09

Compounds and methods of use

#188
20050124626
2005-06-09

Novel compounds

#189
20050119487
2005-06-02

Naphthol derivative and charge control agent comprising the same

#190
20050080267
2005-04-14

Synthesis of enantiomerically pure amino-substituted fused bicyclic rings

#191
20050026942
2005-02-03

Chemokine receptor binding heterocyclic compounds

#192
20050009871
2005-01-13

Ubiquitin ligase inhibitors

#193
20050004367
2005-01-06

Sulfonamide derivatives